HELLO PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
HELLO PHARMA
Largest movements
- Cash +€70,293
up €70,293 (+72.6%), from €96,850 to €167,143
mainly Net result for the year (+€101,939) and Depreciation (+€26,020)
- Tangible fixed assets -€24,633
down €24,633 (-29.1%), from €84,616 to €59,982
of which Furniture and vehicles: -€22,246
- Receivables within one year +€7,189
up €7,189 (+12.4%), from €58,094 to €65,283
of which Trade receivables: +€27,133
- Reserves +€38,649
up €38,649 (+24.5%), from €157,759 to €196,408
- Other debts +€20,713
new in 2025: €20,713
- Debts after one year -€14,858
down €14,858 (-49.9%), from €29,787 to €14,928
- Trade debts +€11,995
up €11,995 (+128.6%), from €9,331 to €21,325
- Gross operating margin +€110,154
up €110,154 (+168.1%), from €65,516 to €175,670
- Taxes +€33,741
up €33,741 (+278.5%), from €12,113 to €45,854
- Other operating charges -€2,868
down €2,868 (-80.6%), from €3,560 to €692
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €248,786 | €302,014 | +€53,229 | +21.4% |
| Fixed assets | 21/28 | €84,616 | €59,982 | -€24,633 | -29.1% |
| Tangible fixed assets | 22/27 | €84,616 | €59,982 | -€24,633 | -29.1% |
| Furniture and vehicles | 24 | €74,058 | €51,812 | -€22,246 | -30.0% |
| Other tangible fixed assets | 26 | €10,558 | €8,170 | -€2,388 | -22.6% |
| Current assets | 29/58 | €164,170 | €242,032 | +€77,862 | +47.4% |
| Amounts receivable within one year | 40/41 | €58,094 | €65,283 | +€7,189 | +12.4% |
| Trade receivables | 40 | €37,149 | €64,283 | +€27,133 | +73.0% |
| Other amounts receivable | 41 | €20,944 | €1,000 | -€19,944 | -95.2% |
| Cash at bank and in hand | 54/58 | €96,850 | €167,143 | +€70,293 | +72.6% |
| Deferred charges and accrued income | 490/1 | €9,227 | €9,606 | +€380 | +4.1% |
| Total equity and liabilities | 10/49 | €248,786 | €302,014 | +€53,229 | +21.4% |
| Equity | 10/15 | €176,359 | €215,008 | +€38,649 | +21.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €157,759 | €196,408 | +€38,649 | +24.5% |
| Distributable reserves | 133 | €157,759 | €196,408 | +€38,649 | +24.5% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €72,426 | €87,006 | +€14,580 | +20.1% |
| Amounts payable after more than one year | 17 | €29,787 | €14,928 | -€14,858 | -49.9% |
| Financial debts | 170/4 | €29,787 | €14,928 | -€14,858 | -49.9% |
| Amounts payable within one year | 42/48 | €42,640 | €71,489 | +€28,849 | +67.7% |
| Current portion of amounts payable after more than one year | 42 | €16,636 | €14,858 | -€1,778 | -10.7% |
| Trade debts | 44 | €9,331 | €21,325 | +€11,995 | +128.6% |
| Suppliers | 440/4 | €9,331 | €21,325 | +€11,995 | +128.6% |
| Taxes, remuneration and social security | 45 | €16,673 | €14,592 | -€2,081 | -12.5% |
| Taxes | 450/3 | €16,673 | €14,592 | -€2,081 | -12.5% |
| Other amounts payable | 47/48 | - | €20,713 | +€20,713 | |
| Accrued charges and deferred income | 492/3 | - | €589 | +€589 | |
| Non-recurring operating income | 76A | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €26,948 | €26,020 | -€927 | -3.4% |
| Other operating charges | 640/8 | €3,560 | €692 | -€2,868 | -80.6% |
| Gross operating margin | 9900 | €65,516 | €175,670 | +€110,154 | +168.1% |
| Operating profit (loss) | 9901 | €35,008 | €148,957 | +€113,949 | +325.5% |
| Financial income | 75/76B | €1,451 | €926 | -€526 | -36.2% |
| Recurring financial income | 75 | €1,451 | €926 | -€526 | -36.2% |
| Financial charges | 65/66B | €1,916 | €2,090 | +€174 | +9.1% |
| Recurring financial charges | 65 | €1,916 | €2,090 | +€174 | +9.1% |
| Profit (loss) for the period before taxes | 9903 | €34,543 | €147,793 | +€113,250 | +327.9% |
| Income taxes | 67/77 | €12,113 | €45,854 | +€33,741 | +278.5% |
| Profit (loss) for the period | 9904 | €22,429 | €101,939 | +€79,509 | +354.5% |
| Profit (loss) for the period to be appropriated | 9905 | €22,429 | €101,939 | +€79,509 | +354.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 September 2026 via checked.be.